Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS)

Cognitive and Behavioral Neurology

Volumn 19, Issue 3, 2006, Pages 165-171

  Grigsby, Jim ^a,g   Leehey, Maureen A ^b   Jacquemont, Sébastien ^d   Brunberg, James A ^f   Hagerman, Randi J ^e   Wilson, Rebecca ^c   Epstein, Jennifer H ^c   Greco, Claudia M ^f   Tassone, Flora ^e   Hagerman, Paul J ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COLORADO   (United States)

Author keywords

Cognition disorders; Executive cognitive function disorders; Fragile X syndrome; FXTAS; Trinucleotide repeats

Indexed keywords

AGED; ANAMNESIS; ARTICLE; ATAXIA; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; FRAGILE X SYNDROME; HUMAN; LANGUAGE DISABILITY; LEARNING; MALE; MEDICAL ASSESSMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SPEECH DISORDER; TREMOR; VERBAL BEHAVIOR; VISUAL ACUITY; WORKING MEMORY;

AGED; ATAXIA; ATTENTION; BRAIN; COGNITION DISORDERS; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; SYNDROME; TREMOR; TRINUCLEOTIDE REPEATS;

EID: 33748541972     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnn.0000213906.57148.01     Document Type: Article

References (74)

1. Oberlè I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 1991;252:1097-1102.
2. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905-914.
3. Brown WT. The molecular biology of the fragile X mutation. In: Hagerman RJ, Cronister A, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research, 2nd ed. Baltimore: Johns Hopkins University Press; 1996:88-113.
4. Hagerman RJ. Fragile X Syndrome. In: Hagerman RJ, ed. Neurodevelopmental Disorders: Diagnosis and Treatment. NY: Oxford University Press; 1999:61-132.
5. Hagerman RJ. Physical and behavioral phenotype. In: Hagerman RJ, Cronister A, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research, 2nd ed. Baltimore: Johns Hopkins University Press; 1996:3-87.
6. Hagerman RJ, Hagerman PJ. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev. 2002;12:278-283.
7. Rousseau F, Rouillard P, Morel ML, et al. Prevalence of carriers of premutation-size alleles of the FMRI gene - and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995;57:1006-1018.
8. Mazzocco MM, Pennington BF, Hagerman RJ. The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr. 1993;14:328-335.
9. Reiss AL, Freund L, Abrams MT, et al. Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet. 1993;52:884-894.
10. Dorn MB, Mazzocco MM, Hagerman RJ. Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry. 1994;33:256-264.
11. Hagerman RJ, Staley LW, O'Connor R, et al. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics. 1996;97:122-126.
12. Loesch DZ, Hay DA, Mulley J. Transmitting males and carrier females in fragile X - revisited. Am J Med Genet. 1994;51:392-399.
13. Riddle JE, Cheema A, Sobesky WE, et al. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard. 1998;102:590-601.
14. Smits A, Smeets D, Hamel B, et al. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length. Am J Med Genet. 1994;51:497-500.
15. Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 messenger RNA in carrier males: a new mechanism of involvement in the fragile X syndrome. Am J Hum Genet. 2000;66:6-15.
16. Tassone F, Hagerman RJ, Taylor AK, et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet. 2000;91:44-152.
17. Franke P, Leboyer M, Gansicke M, et al. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res. 1998;80:113-127.
18. Loesch DZ, Bui QM, Grigsby J, et al. Effect of the fragile X status categories and the FMRP levels on executive functioning in fragile X males and females. Neuropsychology. 2003;17:646-657.
19. Murphy DGM, Mentis MJ, Pietrini P, et al. Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism. J Am Acad Child Adolesc Psychiatry. 1999;38:1294-1301.
20. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism and generalized brain atrophy in older male carriers of fragile X. Neurology. 1991;57:127-130.
21. Grigsby J, Leehey M, Hagerman RJ, et al. Neurodegeneration among older male premutation carriers of Fragile X syndrome. Soc Neurosci Abstr. 2001;27. Poster Session No. 431.8.
22. Leehey MA, Hagerman R, Landau W, et al. Tremor/ataxia syndrome in fragile X carrier males. Mov Disord. 2002;17:744.
23. Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol. 2003;60:117-121.
24. Brunberg JA, Jacquemont S, Hagerman RJ, et al. Fragile X premutation carriers: characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002;23:1757-1766.
25. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. 2002;125:1760-1771.
26. Grigsby J, Hills J, Wilson R, et al. Dysexecutive syndrome in older men with action tremor and the Fragile X premutation. J Int Neuropsychol Soc. 2002;8:282.
27. Grigsby J, Brega A, Jacquemont S, et al. Cognitive impairment among males with the fragile X tremor-ataxia syndrome (FXTAS). Soc Neurosci Abstr. 2004; Program No. 95.8. Online.
28. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72:869-878.
29. Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population: Initial results from a California family-based study. JAMA. 2004;291:460-469.
30. Grigsby J, Brega AG, Jacquemont S, et al. Impairment in the cognitive functioning of men with Fragile X Tremor-Ataxia Syndrome (FXTAS). J Neurol Sci. In press.
31. Hagerman RJ, Leavitt BR, Farzin F, et al. Fragile X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004;74:805-816.
32. Hagerman RJ, Greco C, Chudley A, et al. (2001b) Neuropathology and neurodegenerative features in some older male premutation carriers of fragile X syndrome. (Abstract). Am J Hum Genet. 2001;69(Suppl);A8:177.
33. Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale-Third Edition: Administration and Scoring Manual. San Antonio: The Psychological Corporation; 1997.
34. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia: Lea & Febiger; 1983.
35. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. 2nd ed. Philadelphia: Lea & Febiger; 1983.
36. Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948;39:15-22.
37. Heaton RK. Wisconsin Card Sorting Test (WCST). Odessa, FL: Psychological Assessment Resources; 1981.
38. Grigsby J, Kaye K, Robbins LJ. Reliabilities, norms, and factor structure of the Behavioral Dyscontrol Scale. Percept Mot Skills. 1992;74:883-892.
39. Kaye K, Grigsby J, Robbins LJ, et al. Prediction of independent functioning and behavior problems in geriatric patients. J Am Geriatr Soc. 1990;38:1304-1310.
40. Raven JC. Advanced Progressive Matrices Sets I and II. London: HK Lewis; 1965.
41. Smith A. The Symbol Digit Modalities Test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord. 1968;3:83-91.
42. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2nd ed. NY: Oxford University Press; 1998.
43. Brown J. Some tests of the decay theory of immediate memory. Q J Exp Psychol. 1958;10:12-21.
44. Peterson LR, Peterson MJ. Short-term retention of individual verbal items. J Exp Psychol. 1959;58:193-198.
45. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia (NCCEA). Revised edition. Victoria: University of Victoria Neuropsychology Laboratory; 1977.
46. Wechsler D. WMS-III: Wechsler Memory Scale-Third Edition. San Antonio: Psychological Corporation; 1997.
47. Anzai Y, Simon H. The theory of learning by doing. Psychol Rev. 1979;86:124-180.
48. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1964.
49. Bourgeois JA, Farzin F, Brunberg JA, et al. Dementia with mood symptoms in a fragile X premutation carrier with the Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS): clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci. 2006;18:171-177.
50. Bozeat S, Gregory CA, Ralph MAL, et al. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000;69:178-186.
51. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 2002;58:1608-1615.
52. Della Sala S, Lucchelli F, Spinnler H. Ideomotor apraxia in patients with dementia of the Alzheimer type. Neurology. 1987;234:91-93.
53. Mungas D, Harvey D, Reed BR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65:565-571.
54. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49:786-794.
55. DeCarli C, Haxby JV, Gillette JA, et al. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology. 1992;42:2029-2036.
56. Dubois B, Pillon B. Cognitive and behavioral aspects of basal ganglia diseases. In: Jankovic JJ, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002:530-545.
57. Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology. 2005;64:224-229.
58. Robbins TW, James M, Lange KW, et al. Cognitive performance in multiple system atrophy. Brain. 1992;115:271-291.
59. Pillon B, Gouider-Khouja N, Deweer B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1995;58:174-179.
60. Bak TH, Crawford LM, Hearn VC, et al. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11:268-273.
61. Specht K, Minnerop M, Abele M, et al. In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. Arch Neurol. 2003;60:1431-1435.
62. Kamm C, Healy DG, Quinn NP, et al. The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain. 2005;128:1855-1860.
63. Bürk K, Globas C, Bösch S, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol. 2003;250:207-211.
64. Schelhaas HJ, van de Warrenburg BPC. Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19). Cerebellum. 2005;4:51-54.
65. O'Hearn E, Holmes SE, Calvert PC, et al. SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology. 2001;56:299-303.
66. Vuillaume I, Devos D, Schraen-Maschke S, et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol. 2002;52:666-670.
67. Herman-Bert A, Stevanin G, Netter JC, et al. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.1-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet. 2000;67:229-235.
68. Kertesz A, Martinez-Lage P, Davidson W, et al. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology. 2000;55:1368-1375.
69. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol. 2001;58:1803-1809.
70. Rosen HJ, Gorno-Tempini ML, Goldman WP, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 2002;58:198-208.
71. Kertesz A, McMonagle P, Blair M. The evolution and pathology of frontotemporal dementia. Brain. 2005;128:1996-2005.
72. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol. 2001;102:94-102.
73. Nasreddine ZS, Loginov M, Clark LN, et al. From genotype to phenotype: a clinical, pathological, and biochemical investigation of frontotemporal dementia and Parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol. 1999;45:704-715.
74. Liu W, Miller BL, Kramer JH, et al. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology. 2004;62:742-748.